G Tossing

Summary

Affiliation: Essex pharma
Country: Germany

Publications

  1. ncbi New developments in interferon therapy
    G Tossing
    Essex Pharma GmbH, Tannenstr 15 15a, D 42653 Solingen, Germany
    Eur J Med Res 6:47-65. 2001
  2. ncbi Therapy of chronic hepatitis B and C and treatment options in HCV-HIV co-infection--European Conference on Infectious Diseases and Tropical Medicine, EuCID 2001, 3-6 May 2001, Leipzig
    G Tossing
    Essex Pharma GmbH, Tannenstr 15 15a, D 42653 Solingen, Germany
    Eur J Med Res 6:272-4. 2001
  3. ncbi Interferon-alpha in treatment of chronic hepatitis C in co-infected HIV-patients in combination with ribavirin and as a pre-load therapy in treatment-naive HIV-positive patients. 8th European Conference on Clinical Aspects and Treatment of HIV Infection (
    Gudrun Tossing
    ESSEX Pharma GmbH Muenchen, Tannenstr 15a, D 42653 Solingen, Germany
    Eur J Med Res 7:44-6. 2002
  4. ncbi Clinical management and evidence based treatment of chronic hepatitis C--12th European Congress of Clinical Microbiology and Infectious Diseases, Milan, Italy, 21-24 April 2002
    Gudrun Tossing
    ESSEX Pharma GmbH München, Tannenstr 15a, D 42653 Solingen, Germany
    Eur J Med Res 7:292-4. 2002
  5. ncbi Treating hepatitis C in HIV-HCV coinfected patients
    G Tossing
    ESSEX Pharma GmbH Munich, Solingen, Germany
    Infection 30:329-31. 2002
  6. ncbi Merimepodib (Vertex)
    Gudrun Tossing
    Essex Pharma GmbH, Tannenstrasse 15a, 42653 Solingen, Germany
    IDrugs 6:372-6. 2003
  7. ncbi 99mTc-ciprofloxacin DRAXIMAGE
    Gudrun Tossing
    Essex Pharma GmbH, Tannenstrasse 15a, 42653 Solingen, Germany
    IDrugs 7:374-9. 2004
  8. ncbi 1st International Workshop on HIV Persistence during Therapy. St. Martin, December 10-12, 2003
    Gudrun Tossing
    Essex Pharma GmbH, Tannenstrasse 15 15a, D 42653 Solingen, Germany
    Eur J Med Res 9:83-6. 2004
  9. ncbi Management of chronic hepatitis C in HIV-co-infected patients--results from the First International Workshop on HIV and Hepatitis Co-infection, 2nd-4th December 2004, Amsterdam, Netherlands
    Gudrun Tossing
    ESSEX Pharma GmbH Munich, Tannenstr 15 15a, D 42653 Solingen, Germany
    Eur J Med Res 10:43-5. 2005

Detail Information

Publications9

  1. ncbi New developments in interferon therapy
    G Tossing
    Essex Pharma GmbH, Tannenstr 15 15a, D 42653 Solingen, Germany
    Eur J Med Res 6:47-65. 2001
    ....
  2. ncbi Therapy of chronic hepatitis B and C and treatment options in HCV-HIV co-infection--European Conference on Infectious Diseases and Tropical Medicine, EuCID 2001, 3-6 May 2001, Leipzig
    G Tossing
    Essex Pharma GmbH, Tannenstr 15 15a, D 42653 Solingen, Germany
    Eur J Med Res 6:272-4. 2001
    ....
  3. ncbi Interferon-alpha in treatment of chronic hepatitis C in co-infected HIV-patients in combination with ribavirin and as a pre-load therapy in treatment-naive HIV-positive patients. 8th European Conference on Clinical Aspects and Treatment of HIV Infection (
    Gudrun Tossing
    ESSEX Pharma GmbH Muenchen, Tannenstr 15a, D 42653 Solingen, Germany
    Eur J Med Res 7:44-6. 2002
    ....
  4. ncbi Clinical management and evidence based treatment of chronic hepatitis C--12th European Congress of Clinical Microbiology and Infectious Diseases, Milan, Italy, 21-24 April 2002
    Gudrun Tossing
    ESSEX Pharma GmbH München, Tannenstr 15a, D 42653 Solingen, Germany
    Eur J Med Res 7:292-4. 2002
    ....
  5. ncbi Treating hepatitis C in HIV-HCV coinfected patients
    G Tossing
    ESSEX Pharma GmbH Munich, Solingen, Germany
    Infection 30:329-31. 2002
    ....
  6. ncbi Merimepodib (Vertex)
    Gudrun Tossing
    Essex Pharma GmbH, Tannenstrasse 15a, 42653 Solingen, Germany
    IDrugs 6:372-6. 2003
  7. ncbi 99mTc-ciprofloxacin DRAXIMAGE
    Gudrun Tossing
    Essex Pharma GmbH, Tannenstrasse 15a, 42653 Solingen, Germany
    IDrugs 7:374-9. 2004
    ....
  8. ncbi 1st International Workshop on HIV Persistence during Therapy. St. Martin, December 10-12, 2003
    Gudrun Tossing
    Essex Pharma GmbH, Tannenstrasse 15 15a, D 42653 Solingen, Germany
    Eur J Med Res 9:83-6. 2004
    ..As during suppressive HAART (highly active antiretroviral therapy) a great variety of cells can become HIV-reservoirs, they feature as numerous potential targets for new therapeutic approaches as for instance immune-based therapy...
  9. ncbi Management of chronic hepatitis C in HIV-co-infected patients--results from the First International Workshop on HIV and Hepatitis Co-infection, 2nd-4th December 2004, Amsterdam, Netherlands
    Gudrun Tossing
    ESSEX Pharma GmbH Munich, Tannenstr 15 15a, D 42653 Solingen, Germany
    Eur J Med Res 10:43-5. 2005
    ..This report summarizes some results on epidemiology, pathogenesis, viral interactions, and treatment of chronic hepatitis C in HIV-infected individuals...